Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/02/2012WO2012102562A2 Composition containing novel 4-ｏ-methylhonokiol derivative as active ingredient for treatment of dementia
08/02/2012WO2012102560A2 Novel 4-0-methylhonokiol derivative and composition containing same as active ingredient for treatment of inflammatory diseases
08/02/2012WO2012102555A2 Fucoidan for thrombolysis, derived from seaweed
08/02/2012WO2012102459A1 Novel benzothiazole and benzisothiazole derivatives having 5-ht6 receptor inhibitory activity, preparation method thereof, and pharmaceutical composition containing same
08/02/2012WO2012102405A1 Ring-fused compound
08/02/2012WO2012102404A1 Topical antifungal agent
08/02/2012WO2012102387A1 Pyrazole derivative and pest control agent
08/02/2012WO2012102366A1 Method for producing novel piperazine compound
08/02/2012WO2012102364A1 Composition containing polyunsaturated fatty acid
08/02/2012WO2012102362A1 Pharmaceutical composition containing drug having poor water solubility
08/02/2012WO2012102361A1 Aromatase activator
08/02/2012WO2012102360A1 Morphinan derivative
08/02/2012WO2012102357A1 Bicyclic compound and use thereof for medical purposes
08/02/2012WO2012102355A1 Bicyclic compound and use thereof for medical purposes
08/02/2012WO2012102297A1 Pyrazolopyridine derivative or pharmacologically acceptable salt thereof
08/02/2012WO2012102255A1 Indole derivative and pharmacologically acceptable salt of same
08/02/2012WO2012102254A1 Indole derivative, and pharmacologically acceptable salt thereof
08/02/2012WO2012102242A1 Hydrous adhesive patch
08/02/2012WO2012102216A1 Medical device containing a cake composition comprising aripiprazole as an active ingredient, and a cake composition comprising aripiprazole as an active ingredient
08/02/2012WO2012101846A1 Therapeutic or prophylactic agent for influenza
08/02/2012WO2012101746A1 Tie-2 activator, agent for maturation, normalization, or stabilization of blood vessels, lymph vessel stabilizing agent, wrinkle prevention/improvement agent, and edema improvement/prevention agent
08/02/2012WO2012101605A1 Fgf receptor-activating 3-o-alkyl oligosaccharides, preparation thereof and therapeutic use thereof
08/02/2012WO2012101564A2 Anti-inflammatory compounds
08/02/2012WO2012101487A1 Di/tri-aza-spiro-c9-c11alkanes
08/02/2012WO2012101455A1 Drug delivery systems
08/02/2012WO2012101453A1 Protease activated receptor 2 (par2) antagonists
08/02/2012WO2012101440A1 Local anaesthetic
08/02/2012WO2012101388A1 Novel azacoumarin derivatives having mdr pump inhibiting activity
08/02/2012WO2012101310A1 Method for preparing derivatives of nitric-oxide-donor glycosaminoglycans, the resulting nitroderivatives and the use thereof in the treatment of chronic ulcers
08/02/2012WO2012101292A1 1,2,4-oxadiazole derivatives as drugs modulating the glp-1 peptide receptor
08/02/2012WO2012101263A1 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012WO2012101261A1 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012WO2012101251A1 Human antibodies to pcsk9 for use in methods of treatment based on particular dosage regimens
08/02/2012WO2012101244A1 Trpm8 receptor antagonists
08/02/2012WO2012101242A1 Novel pharmaceutical suspension for parenteral application
08/02/2012WO2012101239A1 Derivatives of azaindazole or diazaindazole type as medicament
08/02/2012WO2012101238A1 New pyrimido[5,4-d]pyrimidylamino phenyl sulfonamides as serine/threonine kinase inhibitors
08/02/2012WO2012101197A1 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
08/02/2012WO2012101186A1 New 5-alkynyl-pyridines
08/02/2012WO2012101184A1 New 5-alkynyl-pyridines
08/02/2012WO2012101181A1 Compositions and methods for cell transplantation
08/02/2012WO2012101173A1 N-methyl-2-pyrrolidone for prevention and treatment of bone loss
08/02/2012WO2012101068A1 Novel tetrahydroquinoline derivatives
08/02/2012WO2012101066A1 Pyridine biaryl amine compounds and their uses
08/02/2012WO2012101064A1 N-acyl pyrimidine biaryl compounds as protein kinase inhibitors
08/02/2012WO2012101063A1 N-acyl pyridine biaryl compounds and their uses
08/02/2012WO2012101062A1 Substituted bi-heteroaryl compounds as cdk9 inhibitors and their uses
08/02/2012WO2012101060A1 Use of nicotinic acetylcholine receptor alpha 7 activators
08/02/2012WO2012101058A1 4-tolyl-ethynyl-octahydro-indole-1-ester derivatives
08/02/2012WO2012101043A1 Pyrazole compounds as crth2 antagonists
08/02/2012WO2012101032A1 Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
08/02/2012WO2012101029A1 Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
08/02/2012WO2012101016A1 Testosterone formulations
08/02/2012WO2012101013A1 Substituted pyridinyl-pyrimidines and their use as medicaments
08/02/2012WO2012100957A1 Inhibitors of branched-chain-aminotransferase-1 (bcat1) for the treatment of brain tumors
08/02/2012WO2012100949A1 Oral dosage forms for modified release comprising tasocitinib
08/02/2012WO2012100948A1 Pharmaceutical compositions comprising tasocitinib
08/02/2012WO2012100931A1 New medical uses of tgf beta 1- specific irna
08/02/2012WO2012100835A1 Methods and compositions for the treatment of aids
08/02/2012WO2012100734A1 Compounds useful as retinoid-related orphan receptor gamma modulators
08/02/2012WO2012100733A1 Fine structure determination method of enoxaparin sodium based on capillary electrophoresis
08/02/2012WO2012100732A1 Retinoid-related orphan receptor gamma modulators, composition containing them and uses thereof
08/02/2012WO2012100723A1 Use of artemisinin b in preparation of antitumor drug
08/02/2012WO2012100704A1 Chiral low-toxicity cb1 receptor inhibitor, preparation method therefor, and use thereof
08/02/2012WO2012100654A1 Ribofuranosyl purine compound, preparation method therefor, and use thereof
08/02/2012WO2012100590A1 Liposome comprising combination of chloroquine and adriamycin and preparation method thereof
08/02/2012WO2012100459A1 Phosphorus substituted group-containing quinoline-like compound, its preparation process, medical composition containing the compound and application
08/02/2012WO2012100436A1 Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof
08/02/2012WO2012100423A1 Analgesic compounds, methods, and formulations
08/02/2012WO2012100408A1 Dextrin inclusion complex, preparation method thereof and pharmaceutical formulation comprising said inclusion complex
08/02/2012WO2012100389A1 Triterpenoid saponin compounds, preparation methods and uses thereof
08/02/2012WO2012100383A1 Refining process of cefamandole sodium
08/02/2012WO2012100368A1 Method for screening tumor cells and use thereof.
08/02/2012WO2012100366A1 Liposome and personal care composition comprising thereof
08/02/2012WO2012100347A1 Compositions comprising a prostaglandin for treating neuropsychiatric conditions
08/02/2012WO2012100342A1 Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
08/02/2012WO2012100295A1 Extended release acetaminophen liquid pharmaceutical compositions
08/02/2012WO2012083061A3 Anti-viral compounds
08/02/2012WO2012083053A3 Anti-viral compounds
08/02/2012WO2012083048A3 Anti-viral compounds
08/02/2012WO2012080729A3 Casein kinase 1delta (ck1delta) inhibitors and their use in the treatment of neurodegenerative diseases such as tauopathies
08/02/2012WO2012078757A3 Combination for breast cancer therapy with hsp90 inhibitory compounds
08/02/2012WO2012078593A3 Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis
08/02/2012WO2012078591A8 Use of laquinimod for reducing fatigue, improving functional status, and improving quality of life in multiple sclerosis patients
08/02/2012WO2012078546A3 Compositions and methods for stabilizing ingredients using 2,4-pentanedione compounds
08/02/2012WO2012078519A3 3-acylidene-2-oxoindole derivatives for inhibition of transglutaminase 2
08/02/2012WO2012076985A3 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
08/02/2012WO2012076973A3 Novel salts of dipeptidyl peptidase iv inhibitor
08/02/2012WO2012075451A3 Clonidine and gaba compounds in a biodegradable polymer carrier
08/02/2012WO2012075393A3 Activators of proteasomal degradation and uses thereof
08/02/2012WO2012075362A3 Chemokine cxcr4 receptor modulators and used related thereto
08/02/2012WO2012075286A9 Intrapulmonary benzodiazepine for the treatment and prevention of seizures
08/02/2012WO2012075048A3 Hybrid cyclic libraries and screens thereof
08/02/2012WO2012071480A3 Lipophilic glucocorticosteroid monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging
08/02/2012WO2012071369A3 A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease
08/02/2012WO2012071221A3 Compositions and methods for once-daily treatment of obsessive compulsive disorder with ondansetron
08/02/2012WO2012068209A3 Bisthiazole inhibitors of pro-matrix metalloproteinase activation
08/02/2012WO2012068109A3 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
08/02/2012WO2012067481A3 Orally administered pharmaceutical composition for the treatment of irritable bowel syndrome, comprising an intestinal motility modifier, an agent that prevents gas retention, and digestive enzymes, and preparation method thereof
08/02/2012WO2012066365A3 Crystalline pharmaceutically active ingredients
1 ... 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 ... 7860